Research study Program year 2021 Source: CMS Open Payments

A Phase 1 Open-label, Single-dose Study to Assess

Research payments

$241,114

9 payments

Through program year 2021, $241,114 in research payments was reported against A Phase 1 Open-label, Single-dose Study to Assess, across 9 payments, paid by Celgene Corporation.

Paid by: Celgene Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$210,894	7
2020	Research	$30,220	2

Breakdown

Who paid Research payments · program years 2020–2021

Celgene Corporation $241,114 9 payments

Who received the money Research payments · program years 2020–2021

Atlantic Clinical Research Collaborative Organisation paid for research $89,887 1 payment
Orlando Clinical Research Center Organisation paid for research $67,546 2 payments
Clinical Research Services, Incorporated Organisation paid for research $47,279 1 payment
Clinical Research Services Organisation paid for research $27,051 1 payment
Alliance For Multispecialty Research Organisation paid for research $6,972 2 payments
Orlando Clinical Rsrch Ct Organisation paid for research $2,028 1 payment
New Orleans Center For Clinical Research Organisation paid for research $350 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

4 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.